Futibatinib, FULVESTRANT
TAS-120-404
Phase 3 small_molecule active
Quick answer
Futibatinib, FULVESTRANT for Malignant Solid Tumors is a Phase 3 program (small_molecule) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiho Pharma Netherlands B.V.
- Indication
- Malignant Solid Tumors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active